Joe G. Hollingsworth is one of the nation’s preeminent trial and appellate lawyers in complex civil litigation and has been honored three times by The National Law Journal for Top Ten Defense Wins of the year. He has conducted over 25 jury trials appearing in over 40 states, and over 100 opinions arising from his cases are published in federal and state reporters. He leads a group of eighty-five attorneys at the firm he founded in 1982, defending major manufacturers in serial products liability claims involving thousands of claimants and pharmaceutical, medical device, chemical, and consumer products, and alleged toxic and environmental torts.
Mr. Hollingsworth recently obtained in the U.S. District Court for the District of Columbia dismissal of claims brought by 3,200 Ecuadorian plaintiffs against DynCorp International for alleged crop, animal, and human health damages in connection with counter-narcotics spraying in Colombia. In the Aredia/Zometa serial litigation. He first-chaired defense verdicts for Novartis Pharmaceuticals Corp. in the first and second bellwether cases in the New Jersey consolidated litigation and he and his team secured defense verdicts in a total of nine trials in the Aredia/Zometa litigation. Mr. Hollingsworth also served as lead counsel for Norfolk Southern in the largest tort case in South Carolina history, where a textile manufacturer sought hundreds of millions of dollars in compensatory and punitive damages for alleged property damage to its plants after a train derailment and chlorine release. After one month of an expected 3-month trial, the parties agreed to a confidential settlement. He conducted the first jury trial involving allegations that hernia repair mesh causes infertility and secured a defense verdict for the nation’s largest medical device manufacturer. Mr. Hollingsworth also tried the first case alleging that the drug Parlodel could cause serious cerebrovascular events in new mothers. The case was tried in Mississippi state court, where he secured a defense verdict that was upheld by the Mississippi Supreme Court. He successfully argued five seminal, widely cited U.S. circuit court Daubert opinions: Rider v. Sandoz (11th Cir. prescription drug); Hollander v. Sandoz (10th Cir. prescription drug); Glastetter v. Novartis (8th Cir. prescription drug); Conde v. Velsicol (6th Cir. pesticide); and Schudel v. GE (9th Cir. solvents).
Mr. Hollingsworth appears as a lecturer in federal and state judge education workshops and seminars, and is consulted frequently on complex litigation strategies. He serves on the Georgetown University Law Center Board of Visitors, as well as on the board of Atlantic Legal Foundation on which he has served since 2008. Mr. Hollingsworth is a Fellow of the Litigation Counsel of America, which recognizes excellence among U.S. litigation and trial counsel, and he is listed in Best Lawyers and Super Lawyers. He received his J.D. from Georgetown University Law Center and his B.A. from DePauw University.